The objectives of this project are to study the stem cell compartment of tile bone marrow, its functional organization, and the implications of this organization on the clinical use of cytotoxic agents, cytokines, and radiation. This project is also directed toward improving autologous hematopoietic stem cell transplantation (HSCT) by optimizing donor marrow engraftment, and long-term recipient hematopoiesis and survival.
Specific aim 1 will determine how cytotoxic agents, radiation, and cytokines affect bone marrow stem cell reserve capacity in a murine model. Mechanisms of marrow damage will be explored by using side population (SP) cells. SP cells, isolated by flow cytometric analysis and sorting, constitute a hematopoietic stem cell (HSC) population with very high long-term repopulating ability in mice. Use of SP cells allows direct measurement of damage to progenitors and primitive stem cells, assessment of the repair capacity of stem cells, and the isolation and study of HSC in S-G2M.
Specific aim 2 will determine how cytotoxic agents and cytokines affect bone marrow stem cell reserve capacity through variations in drug dosing (using a high dose cyclophosphamide (CY) model) and through drug-drug interactions (with fludarabine and CY). Autologous HSCT is increasingly successful for treating a variety of malignancies in the clinic. Experimental and clinical data suggest that prior exposure to cytotoxic agents that damage primitive stem cells results in impaired hematopoiesis and an increased the risk of MDS/AML after autologous HSCT.
Specific aim 3 will determine predictive factors in donor HSC most important for impaired hematopoiesis in patients after autologous HSCT. We will determine the frequency and function of SP cells and CD34+KDR+ cells; two recently described human HSC populations, in normal marrow and in mobilized blood. We will assess which marker(s) in donor autologous marrow and mobilized blood predicts for impaired hematopoiesis after autologous HSCT. Transplanted CD34+38- cell, SP cell, and CD34+KDR+ cell content, and the presence of chromosomal abnormalities pre-transplant will be used as markers of intact hematopoiesis. We will correlate these markers with surrogates for HSC reserve capacity (post-HSCT time to platelet engraftment, impaired long-term hematopoiesis, and development of MDS). The successful completion of this specific aim should allow better identification of patients at high risk for marrow failure after autologous HSCT.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Radiation Study Section (RAD)
Program Officer
Stone, Helen B
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dana-Farber Cancer Institute
United States
Zip Code
Jiang, Shuxian; Alberich-Jorda, Meritxell; Zagozdzon, Radoslaw et al. (2011) Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood 117:827-38
Parmar, Kalindi; Mauch, Peter; Vergilio, Jo-Anne et al. (2007) Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A 104:5431-6
Parmar, Kalindi; Burdick, Daniel; Ethier, Matthew et al. (2005) Murine side population cells contain cobblestone area-forming cell activity in mobilized blood. Stem Cells Dev 14:452-61
Parmar, Kalindi; Sauk-Schubert, Calies; Burdick, Daniel et al. (2003) Sca+CD34- murine side population cells are highly enriched for primitive stem cells. Exp Hematol 31:244-50
van Os, R; Sheridan, T M; Robinson, S et al. (2001) Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model. Stem Cells 19:80-7
Robinson, S N; Freedman, A S; Neuberg, D S et al. (2000) Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment. Exp Hematol 28:1325-33
van Os, R; Robinson, S; Sheridan, T et al. (2000) Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal. Stem Cells 18:120-7
van Os, R; Robinson, S N; Drukteinis, D et al. (2000) Respiratory burst of neutrophils is not required for stem cell mobilization in mice. Br J Haematol 111:695-9
van Os, R; Avraham, H; Banu, N et al. (1999) Recombinant adeno-associated virus-based vectors provide short-term rather than long-term transduction of primitive hematopoietic stem cells. Stem Cells 17:117-20
van Os, R; Robinson, S; Sheridan, T et al. (1998) Granulocyte colony-stimulating factor enhances bone marrow stem cell damage caused by repeated administration of cytotoxic agents. Blood 92:1950-6

Showing the most recent 10 out of 28 publications